Comments on: Artisan Raises $9.4M in Debt Round http://www.xconomy.com/boston/2009/05/13/24615/ Business + Technology in the Exponential Economy Fri, 10 Feb 2012 17:53:35 +0000 hourly 1 http://wordpress.org/?v=3.0.4 By: Financings and More Venture Updates - Metabolic Solutions, Addrenex, Artisan | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes http://www.xconomy.com/boston/2009/05/13/24615/comment-page-1/#comment-57810 Financings and More Venture Updates - Metabolic Solutions, Addrenex, Artisan | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes Thu, 14 May 2009 00:48:18 +0000 http://www.xconomy.com/?p=24615#comment-57810 [...] Artisan Pharma has raised $9.4M of an $11.8M round of debt financing. Artisan’s lead drug is recombinant thrombomodulin, an anticlotting drug licensed from Asahi Kasei Pharma. Investors were not disclosed. [Xconomy] [...] [...] Artisan Pharma has raised $9.4M of an $11.8M round of debt financing. Artisan’s lead drug is recombinant thrombomodulin, an anticlotting drug licensed from Asahi Kasei Pharma. Investors were not disclosed. [Xconomy] [...]

]]>